Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533)
Keywords: اختلال نعوظ نر; PDE5; PDE6; PDE11; Enzyme inhibitor; Metabolic stability; Quinazoline; Male erectile dysfunction